In joint analyses, combined ALI–ePWV categories showed a risk gradient: participants with high ALI/low ePWV had the lowest risks of all-cause mortality and premature mortality compared with those with low ALI/high ePWV.
Abstract
Adults with prediabetes or diabetes and cardiovascular disease (CVD) face a substantial burden of premature mortality. Chronic inflammation, malnutrition and vascular aging are key pathways linking dysglycaemia and CVD to adverse outcomes. The Advanced Lung Cancer Inflammation Index (ALI) reflects systemic inflammation and nutritional status, while estimated pulse wave velocity (ePWV) serves as a surrogate of vascular aging. However, their independent and joint associations with mortality in dysglycemic adults with CVD remain unclear.
NHANES 1999–2018 data comprising 101,316 participants were analyzed. After exclusions, adults ≥ 20 years with prediabetes/diabetes and CVD were included (
n
= 1,992). ALI and ePWV were analysed as continuous variables and cross-classified using maximally selected cut-points. Survey-weighted Cox models, restricted cubic splines and subgroup/sensitivity analyses were applied. Time-dependent receiver operating characteristic curves and C-indices were used to compare prognostic discrimination.
Higher ALI was inversely associated with all-cause, cardiovascular, and premature mortality, whereas higher ePWV was positively associated with all-cause and cardiovascular mortality. Per 10-unit increment in ALI, fully adjusted hazard ratios (HRs) were 0.899 (95% CI 0.872–0.928) for all-cause mortality, 0.938 (0.885–0.995) for cardiovascular mortality, and 0.889 (0.837–0.945) for premature mortality. For ePWV, the corresponding HRs per 1 m/s increment were 1.139 (1.072–1.211) for all-cause mortality and 1.216 (1.102–1.341) for cardiovascular mortality. In joint analyses, combined ALI–ePWV categories showed a risk gradient: participants with high ALI/low ePWV had the lowest risks of all-cause mortality (HR 0.382, 95% CI 0.280–0.520), cardiovascular mortality (HR 0.379, 95% CI 0.228–0.630), and premature mortality (HR 0.402, 95% CI 0.245–0.659) compared with those with low ALI/high ePWV.
ALI and ePWV provide complementary information on systemic inflammation–nutrition status and vascular ageing, and their combined categories define distinct risk strata for mortality in adults with dysglycaemia and CVD. Their combined categories may help characterize mortality-risk heterogeneity and inform future risk-assessment studies in this high-risk population.
BACKGROUND
Chronic inflammation and insulin resistance (IR) are key drivers of cardiovascular disease (CVD); however, their joint impact on cardiovascular risk remains poorly understood.
METHODS
We developed the metabolic-inflammatory index (eMII) based on estimated glucose disposal rate (eGDR) in a derivation cohort...
Meng-Lu Liu, N. Xu, Geng-Yu Sha et al.· Diabetes, obesity and metabo...· 0 citations
The weight-adjusted waist index (WWI), a recently proposed marker reflecting central fat distribution independent of body weight, has emerged as a potential indicator of metabolic and cardiovascular risk. Considering the high burden of inflammation and metabolic disturbance in chronic kidney disease (CKD), we examined...
Cardiovascular-kidney-metabolic (CKM) syndrome integrates metabolic abnormalities, chronic kidney disease, and cardiovascular disease (CVD), with stages 0–3 representing a critical window for primary prevention. Whether the Chinese visceral adiposity index (CVAI) adds predictive value for CVD in this population r...
Long Feng, Geng Yang, He-Song Zeng et al.· Cardiovascular Diabetology· 0 citations
Metabolic dysfunction-associated steatotic liver disease (MASLD) is being increasingly recognized as a systemic cardiometabolic disorder rather than a liver-limited condition. However, the combined association of insulin resistance, systemic inflammation, and depressive symptoms with mortality remains unclear. Therefor...
Yan Chen, Kai-Ling Xie, Ning-Kun Xiao et al.· Lipids in Health and Disease· 0 citations
To examine the associations of cardiometabolic burden with transitions from CVD-free status to incident CVD, death without prior CVD, and death after CVD among individuals with MASLD, and to further characterize non-linear patterns, temporal variations, and potential contributing factors related to these associatio...
Chuan-Yong Cui, Yi Zhao, Guang-Ji Zhang et al.· Frontiers in Nutrition· 0 citations
Objectives: Individuals with type 2 diabetes (T2D) remain at high cardiovascular disease (CVD) risk. The pan-immune-inflammation value (PIV) integrates circulating neutrophils, monocytes, platelets, and lymphocytes but does not capture albumin-related nutritional and inflammatory reserve. We investigated associations b...
Fang-Kun Liu, Xing-Hua Yang, Bo Gao et al.· Biomedicines· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.